Understanding COVID-19-associated coagulopathy (Podcast Episode 29)

This episode is shared from Lab Medicine Rounds.

Guest: Ariela L. Marshall, M.D. (@AMarshallMD)

Host: Justin D. Kreuter, M.D. (@KreuterMD

What is COVID-19-associated coagulopathy? Why is it so important to recognize early on? How does it differ from typical disseminated intravascular coagulation (DIC)? Ariela L. Marshall, M.D., details the lab patterns, implications for our patients, and what testing should be evaluated on patients being treated for COVID-19 and when.

Subscribe to Lab Medicine Rounds here: https://news.mayocliniclabs.com/podcast/lab-medicine-rounds/

AskMayoExpert COVID-19 Navigator resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

This education is supported in part by an independent medical education grant from Pfizer Inc. and is in accordance with ACCME guidelines.

Click here to claim credit and view faculty disclosures. Select Register to begin the credit claim process.

Connect with Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu or on Twitter @MayoMedEd.


Published

August 6, 2020

Created by

Mayo Clinic